Granulocyte-macrophage colony stimulating factor protects dendritic cells from anticancer drug-induced apoptosis

수지상세포에서 GM-CSF의 항암제유도 세포사멸 방지효과에 관한 연구

  • Joo, Hong-Gu (Department of Veterinary Medicine, Cheju National University)
  • Accepted : 2003.11.20
  • Published : 2003.12.25

Abstract

Dendritic cells (DCs) play an essential role in a variety of immune reactions involving $CD4^+$ T cells and have been used to enhance tumor-specific immune responses. Immunosuppression in patients with cancer includes the downregulation of function and number of DCs. Although DCs have been studied, the apoptosis of Des induced by anticancer drugs for chemotherapy remains largely uncharacterized. This study demonstrated that GM-CSF protects DCs from 5-fluorouracil (5-FU) or mitomycin C-induced apoptosis. After 6 - 10 days culture, DCs were characterized by specific surface marker, CD11c and MHC class II. MTT assay revealed that GM-CSF significantly enhanced the viability of DCs treated with 5-FU or mitomycin C. The percentage of dead cells of DCs was determined by cell size using FACScan and GM-CSF was clearly effective. However, GM-CSF did not increase the expression of MHC class II on viable DCs gated, suggesting that GM-CSF may differentially regulate critical factors involved in the function of DCs. For the quantitative analysis of apoptosis, annexin V-FITC staining was performed. 5-FU induced the apoptosis of DCs and GM-CSF significantly protects DCs from 5-FU-induced apoptosis. Taken together, the results in this study that GM-CSF has an anti-apoptosis effect on DCs may provide patients with cancer with clinical benefits to overcome the immunosuppression induced by the decrease of number and functional insufficiency of DCs.

Keywords

References

  1. Banchereau, J. and Steinman, R. M. Dendritic cells and the control of immunity. Nature 1998, 392, 245-252
  2. Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., kavanaush, D. and Carbone, D. P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Medicine 1996, 2(10), 1096-1103
  3. Inaba, K., Inaba, M., Roniani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. and Steinman, R. M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 1992, 176(6), 1693-1702
  4. Joo, H.-G., Fleming, T. P., Tanaka, Y., Dunn, T. J., Linehan, D. C., Goedegebuure, P. S. and Eberlein, T. J, Human dendritic cells induce tumor-specific apoptosis by soluble factors, Int. J. Cancer 1002, 102(1), 20-28
  5. Keane, T. E., Gingrich, J. R., Rosner, G., Webb, K. S., Poulton, S. H. and Walther, P. J. Combination versus single agent therapy in effecting complete therapeutic response in human bladder cancer: analysis of cisplatin and/or 5-fluorouracil in an in vivo survival model. Cancer Res. 1994, 54(2), 475-481
  6. Kiertscher, S. M., Luo, J., Dubinett, S. M. and Roth, M. D. Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J. Immunol. 2000, 164(3), 1269-1276
  7. Martin, S. J., Reutelingsperger, C. P., McGahon, A. J., Rader, J. A., van Schie, R. C., LaFace, D. M. and Green, D. R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 1995, 182(5), 1545-1556
  8. Morstyn, G. and Burgess, A. W. Hematopoietic growth factors: a review. Cancer Res. 1988, 48(20), 5624-5637
  9. Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G. and Schadendorf, D. Vaccination of inelaiioma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature Medicine 1998. 4(3), 328-332
  10. Pinedo, H. M., Buter, J., Luykx-de Bakker, S. A., Pohlmann, P. R., van Hensbergen, Y., Heideman, D. A. M., van Diest, P. J., de Gruijl, T. D. and van der Wall, E. Extended neuadjuvunt chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumor-draining lymph node dendritic cells. Eur. J. Cancer 2003, 39(8), 1061-1067
  11. Shimizu, S., Eguchi, Y., Kamiike, W., Itoh, Y., Hasegawa, J., Yamabe, K., Otsuki, Y., Matsuda, H. and Tsujimoto, Y. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Re.s. 1996, 56(9), 2161-2166
  12. Suk, K., Chang, I., Kim, Y.-H., Kim, S., Kim, J. Y., Kim, H. and Lee, M.-S. Intertferon $\gamma$ (IFN$\gamma$) and tumor necrosis factor $\alpha$ synergism in ME-180 cervical cancer cell apoptusis and necrosis: IFN$\gamma$ inhibits cytoprotective NF-KB through STATl/IRF-I pathways. J. Biol. Chem. 2001, 276(16), 13153-13159
  13. Talmor, M., Mirza, A., Ttirley, S., Mellman, I., Hoffman, L. A. and Steinman, R. M. Generation or large numbers of immature and mature dendritic cells from rat bone marrow cultures. Eur. J. Immunol. 1998, 28(3), 811-817
  14. Tanaka, F., Yamaguchi, H., Ohta, M., Mashino, K., Sonoda, H., Sadanaga, N., Inoue, H. and Mori, M. Intratumoral injection of dendritic cells after treatment of anticancer drugs induces tumor-specific antitumor effect in vivo. Int. J. Cancer 2002. 101(3), 265-269
  15. Vremec, D., Pooley, J., Hochrein, H., Wu, L. and Shortman, K. CD4 and CD8 expression by dendritic cells subtypes in mouse thymus and spleen. J. Immunol. 2000, 164(6), 2978-2986